Edwards Lifesciences total liabilities and share holders equity for the quarter ending September 30, 2024 was $12.971B, a 38.42% increase year-over-year.
Edwards Lifesciences total liabilities and share holders equity for 2023 was $9.363B, a 12.91% increase from 2022.
Edwards Lifesciences total liabilities and share holders equity for 2022 was $8.293B, a 2.47% decline from 2021.
Edwards Lifesciences total liabilities and share holders equity for 2021 was $8.503B, a 17.49% increase from 2020.
Edwards Lifesciences Total Liabilities and Share Holders Equity 2010-2024 | EW